Literature DB >> 31662503

Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines.

Takashi Miwa1, Mitsuro Kanda2, Shinichi Umeda1, Haruyoshi Tanaka1, Dai Shimizu1, Chie Tanaka1, Daisuke Kobayashi1, Masamichi Hayashi1, Suguru Yamada1, Goro Nakayama1, Masahiko Koike1, Yasuhiro Kodera1.   

Abstract

BACKGROUND/AIM: Establishment of mouse xenograft models is necessary for oncological research and depends on the characteristics of the cell lines and the immune system of the host. In this study, we describe the development of mouse xenograft models using human gastric cancer (GC) cell lines.
MATERIALS AND METHODS: MKN1 stably-expressing luciferase (MKN1-Luc), N87, KATO III, MKN45 stably-expressing luciferase (MKN45-Luc), NUGC4, and OCUM-1 human GC cell lines were injected intraperitoneally into mice to establish peritoneal metastasis models. MKN45-Luc were injected into subcutaneously implanted spleen, and MKN1-Luc and MKN45-Luc were injected directly into the portal veins of mice for the establishment of hepatic metastasis models.
RESULTS: Peritoneal metastasis was formed after implantation of MKN1-Luc, N87, KATO III, MKN45-Luc, and NUGC4 in nude mice, but not formed in OCUM-1 even in NOD/SCID mice. After intrasplenic injection of MKN45-Luc, we found no hepatic metastasis formation. We identified hepatic metastasis formation after direct injection of MKN45-Luc and MKN1-Luc into the portal veins of NOD/SCID mice.
CONCLUSION: Peritoneal and hepatic metastasis mouse xenograft models were successfully established using several human GC cell lines. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Gastric cancer; hepatic metastasis; peritoneal metastasis; xenograft

Mesh:

Year:  2019        PMID: 31662503      PMCID: PMC6899157          DOI: 10.21873/invivo.11669

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  36 in total

1.  Continuous low-dose irradiation by I-125 seeds induces apoptosis of gastric cancer cells regardless of histological origin.

Authors:  Kaoru Takabayashi; Kazuhiro Kashiwagi; Tetsuya Kawata; Toshiro Sato; Katsuyoshi Matsuoka; Tadakazu Hisamatsu; Hiromasa Takaishi; Toshifumi Hibi; Haruhiko Ogata; Naohisa Yahagi; Yuko Kitagawa; Naoyuki Shigematsu; Takanori Kanai
Journal:  Cancer Biol Ther       Date:  2013-10-22       Impact factor: 4.742

2.  Origins of lymphatic and distant metastases in human colorectal cancer.

Authors:  Kamila Naxerova; Johannes G Reiter; Elena Brachtel; Jochen K Lennerz; Marc van de Wetering; Andrew Rowan; Tianxi Cai; Hans Clevers; Charles Swanton; Martin A Nowak; Stephen J Elledge; Rakesh K Jain
Journal:  Science       Date:  2017-07-07       Impact factor: 47.728

3.  Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene.

Authors:  Timothy M Pawlik; Hideo Nakamura; John T Mullen; Hideki Kasuya; Sam S Yoon; Soundararajalu Chandrasekhar; E Antonio Chiocca; Kenneth K Tanabe
Journal:  Cancer       Date:  2002-09-01       Impact factor: 6.860

4.  Blood kinetics, tissue distribution, and radioimaging of anti-common chronic lymphatic leukemia antigen (cCLLa) monoclonal antibody CLL2 in mice transplanted with cCLLa-bearing human leukemia cells.

Authors:  G B Faguet; J F Agee; J T DiPiro
Journal:  Blood       Date:  1990-05-01       Impact factor: 22.113

5.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

Authors:  Shinichi Sakuramoto; Mitsuru Sasako; Toshiharu Yamaguchi; Taira Kinoshita; Masashi Fujii; Atsushi Nashimoto; Hiroshi Furukawa; Toshifusa Nakajima; Yasuo Ohashi; Hiroshi Imamura; Masayuki Higashino; Yoshitaka Yamamura; Akira Kurita; Kuniyoshi Arai
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

6.  Experimental model for liver metastasis formation using Lewis lung tumor.

Authors:  L Kopper; T Van Hanh; K Lapis
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

7.  Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.

Authors:  Nan Hu; Jun Feng Yin; Ze Ji; Yidong Hong; Puyuan Wu; Baoxiang Bian; Ziyan Song; Rutian Li; Qin Liu; Fenglei Wu
Journal:  Cell Physiol Biochem       Date:  2017-12-12

8.  Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.

Authors:  I C Gerling; D V Serreze; S W Christianson; E H Leiter
Journal:  Diabetes       Date:  1992-12       Impact factor: 9.461

9.  [Establishment and characterization of a new gastric cancer cell line (OCUM-1), derived from Borrmann type IV tumor].

Authors:  T Kubo
Journal:  Nihon Geka Gakkai Zasshi       Date:  1991-10

10.  Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry.

Authors:  Atsushi Nashimoto; Kohei Akazawa; Yoh Isobe; Isao Miyashiro; Hitoshi Katai; Yasuhiro Kodera; Shunichi Tsujitani; Yasuyuki Seto; Hiroshi Furukawa; Ichiro Oda; Hiroyuki Ono; Satoshi Tanabe; Michio Kaminishi
Journal:  Gastric Cancer       Date:  2012-06-23       Impact factor: 7.370

View more
  11 in total

1.  Investigating the mechanisms of peritoneal metastasis in gastric adenocarcinoma using a novel ex vivo peritoneal explant model.

Authors:  Marco Magalhaes; Carol J Swallow; Deanna Ng; Aiman Ali; Kiera Lee; Denise Eymael; Kento Abe; Shelly Luu; Karineh Kazazian; Yi Qing Lu; Savtaj Brar; James Conner
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

2.  miR-502-5p affects gastric cancer progression by targeting PD-L1.

Authors:  Wendao You; Xiaoyu Liu; Yang Yu; Chen Chen; Yujia Xiong; Yiting Liu; Yibin Sun; Chenhuan Tan; Hanshuo Zhang; Yadong Wang; Rui Li
Journal:  Cancer Cell Int       Date:  2020-08-15       Impact factor: 5.722

3.  miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cells.

Authors:  Narjes Jafari; Saeid Abediankenari; Hadi Hossein-Nataj
Journal:  Cancer Cell Int       Date:  2021-03-19       Impact factor: 5.722

4.  Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer.

Authors:  Wencheng Kong; Xinchun Liu; Guang Yin; Sixin Zheng; Akao Zhu; Panpan Yu; Yuqiang Shan; Rongchao Ying; Jian Zhang
Journal:  Aging (Albany NY)       Date:  2020-11-18       Impact factor: 5.682

5.  Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway.

Authors:  Takashi Miwa; Mitsuro Kanda; Dai Shimizu; Shinichi Umeda; Koichi Sawaki; Haruyoshi Tanaka; Chie Tanaka; Norifumi Hattori; Masamichi Hayashi; Suguru Yamada; Goro Nakayama; Masahiko Koike; Yasuhiro Kodera
Journal:  Br J Cancer       Date:  2021-02-03       Impact factor: 7.640

6.  Large-Scale Gastric Cancer Susceptibility Gene Identification Based on Gradient Boosting Decision Tree.

Authors:  Qing Chen; Ji Zhang; Banghe Bao; Fan Zhang; Jie Zhou
Journal:  Front Mol Biosci       Date:  2022-01-13

7.  MicroRNA miR-495 regulates the development of Hepatocellular Carcinoma by targeting C1q/tumor necrosis factor-related protein-3 (CTRP3).

Authors:  Ruiguang Zhang; Chunxia Guo; Ting Liu; Wenting Li; Xiliu Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Effects of wogonin on the growth and metastasis of colon cancer through the Hippo signaling pathway.

Authors:  Wenli You; Aiting Di; Lize Zhang; Gang Zhao
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

9.  Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer.

Authors:  Mitsuro Kanda; Dai Shimizu; Koichi Sawaki; Shunsuke Nakamura; Shinichi Umeda; Takashi Miwa; Haruyoshi Tanaka; Chie Tanaka; Masamichi Hayashi; Yohei Iguchi; Suguru Yamada; Masahisa Katsuno; Yasuhiro Kodera
Journal:  Mol Cancer       Date:  2020-08-26       Impact factor: 27.401

10.  Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling.

Authors:  Ji Zhou; Yang Peng; Ying-Chun Gao; Tai-Yu Chen; Peng-Cheng Li; Ke Xu; Tao Liu; Tao Ren
Journal:  Cancer Cell Int       Date:  2021-07-03       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.